Contract analysis

1. Text of the Agreed Joint Public Statement The following constitutes the exclusive, agreed-upon statement (the "Agreed Statement") to be used by either Party (or such Party's respective counsel, officers, directors, employees, agents, or other authorized representatives) when making any public statement, press release, response to media inquiry, response to investor or analyst inquiry, or other public communication

2. Restrictions on Additional Disclosure 2.1 General Prohibition. Neither Party shall issue, authorize, cause to be issued, or permit to be issued on its behalf any press release, public filing (including any filing with the United States Securities and Exchange Commission or any foreign securities regulatory authority), social media post, blog entry, website publication, investor communication, analyst communication

3. Authorized Spokespersons 3.1 Designation of Spokespersons. The following individuals are designated as authorized spokespersons for each Party and are the only individuals permitted to deliver the Agreed Statement on behalf of their respective Parties: (a) For the Solstice Parties (Solstice Biomedical Devices Ltd. and Solstice Biomedical, Inc.): (i) Dr. Fiona Tierney, Chief Executive Officer, Solstice Biomedical D

4. Effective Date and Duration 4.1 Effective Date. This Agreed Joint Public Statement shall become effective immediately upon the execution and delivery of the Settlement Agreement by all Parties, which execution and delivery is anticipated to occur on June 16, 2025 (the "Effective Date"). 4.2 Survival. The obligations set forth in this Exhibit F, including, without limitation, the restrictions on public disclosure i

5. Governing Law This Exhibit F shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any choice-of-law or conflict-of-laws rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. This governing law provision is consistent with, and sup

6. General Provisions 6.1 Incorporation into Settlement Agreement. This Exhibit F is an integral part of the Settlement Agreement and is incorporated therein by reference. In the event of any conflict between the terms of this Exhibit F and the terms of the body of the Settlement Agreement with respect to the subject matter hereof, the more restrictive provision shall control. 6.2 Remedies. The Parties acknowledge an